1. Home
  2. WING vs IDYA Comparison

WING vs IDYA Comparison

Compare WING & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wingstop Inc.

WING

Wingstop Inc.

N/A

Current Price

$120.58

Market Cap

4.4B

ML Signal

N/A

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

N/A

Current Price

$33.50

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WING
IDYA
Founded
1994
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
3.6B
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
WING
IDYA
Price
$120.58
$33.50
Analyst Decision
Buy
Strong Buy
Analyst Count
28
16
Target Price
★ $187.92
$52.38
AVG Volume (30 Days)
★ 1.0M
738.6K
Earning Date
10-28-2026
11-10-2026
Dividend Yield
★ 1.07%
N/A
EPS Growth
★ 67.84
61.90
EPS
★ 2.23
N/A
Revenue
★ $696,853,000.00
$218,710,000.00
Revenue This Year
$9.28
N/A
Revenue Next Year
$15.57
$188.45
P/E Ratio
$55.04
★ N/A
Revenue Growth
11.35
★ 3024.43
52 Week Low
$95.82
$26.81
52 Week High
$302.80
$42.68

Technical Indicators

Market Signals
Indicator
WING
IDYA
Relative Strength Index (RSI) 51.71 38.53
Support Level $116.35 $29.74
Resistance Level $126.24 $35.14
Average True Range (ATR) 6.32 1.38
MACD -0.48 -0.08
Stochastic Oscillator 24.00 24.43

Price Performance

Historical Comparison
WING
IDYA

About WING Wingstop Inc.

Wingstop is a fast casual restaurant concept built around a simple chicken-centric menu. The firm primarily offers bone-in and boneless wings, tenders, and a chicken sandwich, customizable across 12 flavors. The banner generated $5.3 billion in system sales in 2025 across 3,056 units, with 85% located in the US. Wingstop largely operates as a franchisor, with 98% of units franchised, and earns revenue largely from collecting royalties and advertising fees paid by franchisees, with a smaller contribution from company-owned restaurant sales.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: